Improving Patient Understanding of Preeclampsia

This study has been completed.
Sponsor:
Information provided by:
Northwestern University
ClinicalTrials.gov Identifier:
NCT01119183
First received: April 23, 2010
Last updated: July 22, 2011
Last verified: July 2011
  Purpose

Participants counseled with the preeclampsia educational tool will have a better understanding of preeclampsia than those not counseled using the tool.


Condition Intervention
Preeclampsia
Behavioral: No intervention for this arm
Behavioral: ACOG education pamphlet on preeclampsia
Behavioral: Preeclampsia education tool

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Improving Patient Understanding of Preeclampsia

Resource links provided by NLM:


Further study details as provided by Northwestern University:

Primary Outcome Measures:
  • Improved understanding of preeclampsia [ Time Frame: one week ] [ Designated as safety issue: No ]
    Understanding of preeclampsia will be assessed through a questionnaire that asks a series of closed ended questions about preeclampsia as well as a single open ended question. This questionnaire has been used in a prior study and has proven to be a useful assessment of patient knowledge.


Estimated Enrollment: 120
Study Start Date: April 2010
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1 Behavioral: No intervention for this arm
No educational literature will be offered to this group
Active Comparator: 2 Behavioral: ACOG education pamphlet on preeclampsia
The ACOG pamphlet on preeclampsia will be offered to this group
Experimental: 3 Behavioral: Preeclampsia education tool
The newly created preeclampsia educational tool will be offered to this group

  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 12-40 weeks pregnant
  • No significant hearing or vision impairment
  • English speaking

Exclusion Criteria:

  • Active diagnosis of preeclampsia
  • Significant hearing or vision impairment
  • Non-English speaking
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01119183

Locations
United States, Illinois
Northwestern University
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
  More Information

No publications provided by Northwestern University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: William Grobman, MD, MBA, Associate Professor, Northwestern University
ClinicalTrials.gov Identifier: NCT01119183     History of Changes
Other Study ID Numbers: STU00006039
Study First Received: April 23, 2010
Last Updated: July 22, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Northwestern University:
Patient understanding and counseling

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on July 29, 2014